chartexchange

INM
InMed Pharmaceuticals Inc. Common Shares
stockNASDAQ

Market OpenNov 5, 2026 10:22:49 AM EST
15.41USD+76.114%(+6.66)14,229
12.04Bid18.84Ask6.80Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Vancouver, BC, Canada
Previous Close
$1.76
Beta
4.31
52-Week High
$9.15 2026-11-04
52-Week Low
$0.58 2026-03-31
SMA 50
$1.54
SMA 200
$1.25
Avg. Vol 10D
100,018
Avg. Vol 30D
59,120
Avg. Vol 90D
668,631
Relative Vol
0.08
4.64M
104.1300%
303
Nov 14, 2024 · 1-for-20 (reverse)
INM Profile

inmed is a clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. inmed's proprietary platform technology, product pipeline and accelerated development pathway are the fundamental value drivers of the company.

INM Performance
PeriodPriceDateChangeBeta
1W1.632026-10-29+780.31%118.322
1M1.332026-10-05+975.56%56.750
3M1.402026-08-05+921.79%27.248
6M0.742026-05-05+1833.11%7.607
1Y1.732025-11-05+726.88%4.314
2Y4.502024-11-05+217.89%—
5Y735.002021-11-05-98.05%1.557
INM Stock Summary

InMed Pharmaceuticals Inc. Common Shares (NASDAQ:INM) stock price today is $14.31, and today's volume is 4,965. INM is up 63.486% today. The 30 day average volume is 59,120. INM market cap is $78.59M with 5.49M shares outstanding.